, Tracking Stock Market Picks
Enter Symbol:
EURAND N.V. (EURX) [hlAlert]

down 9.03 %

EURAND N.V. (EURX) rated Outperform with price target $16 by Oppenheimer

Posted on: Thursday,  Jun 25, 2009  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform EURAND N.V. (NASDAQ: EURX) on 06/25/2009, when the stock price was $13.17. Since
then, EURAND N.V. has lost 9.04% as of 03/03/2011's recent price of $11.98.
If you would have followed this Oppenheimer's recommendation on EURX, you would have lost 9.03% of your investment in 616 days.

Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company. The Company develops, manufactures and commercializes pharmaceutical and biopharmaceutical products based on its drug formulation technologies. Through its collaboration arrangements, Eurand has applied its technologies to drug products in a range of therapeutic areas, including cardiovascular, gastrointestinal, pain, nutrition and respiratory. It develops and commercializes its own portfolio of products to address cystic fibrosis and gastrointestinal disorders. Eurand is an established business with manufacturing and research facilities in the United States, Italy and France. It manufactures and supplies over 40 different products for sale in pharmaceutical markets.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/25/2009 8:25 AM Buy
13.17 16.00
as of 12/31/2009
1 Week down  -7.85 %
1 Month up  0.16 %
3 Months down  -20.93 %
1 YTD down  -9.11 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy